Email
Print
Antibiotics Drugs Market size is estimated to reach $65.3 billion by 2027,
growing at a CAGR of 5.2% during the forecast period 2022-2027. Antibiotics
Drugs, also termed antibacterials, are medicines that decimate or delay the
development of bacteria. They involve a series of potent medications and are
utilized to treat ailments brought about by bacteria. Fluoroquinolones
antibiotics are endorsed to treat some bacterial contaminations and have been utilized
for over 30 years. They perform by destroying or halting the development of
bacteria that can bring about sickness. An example of an antibiotic utilized
against parasites is metronidazole, typically branded under the term Flagyl. Cephalosporins
are a massive class of antibiotics that belong to a class termed beta-lactams.
These medications are utilized to treat bacterial contaminations inclusive of
Ear infections. Pneumonia. Skin infections. Kidney infections and sexually
transmitted infections like gonorrhea. Cell wall synthesis inhibitors involve
antibiotics of class-lactams and Glycopeptides.
The soaring requirement for the development of medications and treatment
for COVID-19 is set to drive the Antibiotics Drugs Market. The emerging
predominance of bacterial contaminations requiring the application of fluoroquinolones
antibiotics in conjunction with the requirement for efficient and novel
antibiotics is set to propel the growth of the Antibiotics Drugs Market during
the forecast period 2022-2027. This represents the Antibiotics Drugs Industry
Outlook.
Report
Coverage
The report: “Antibiotics Drugs Market Forecast
(2022-2027)”, by Industry ARC, covers an in-depth analysis of the following
segments of the Antibiotics
Drugs Market.
Key Takeaways
- Geographically, Asia-Pacific Antibiotics Drugs Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the soaring intake of antibiotics like fluoroquinolones antibiotics and the increasing predominance of infectious ailments in the Asia-Pacific region.
- Antibiotics Drugs Market growth is being driven by the developments in generic drugs, the application of antibiotics against the parasites and the surging susceptible population of the elderly. However, certain issues connected with antibiotic resistance and long and monotonous regulatory processes are some of the major factors hampering the growth of the Antibiotics Drugs Market.
- Antibiotics Drugs Market Detailed Analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Antibiotics Drugs Market report.
Antibiotics Drugs Market: Market Share (%) by Region, 2021
For more details on this report - Request for Sample
Antibiotics
Drugs Market Segment Analysis – By Product Type:
The Antibiotics Drugs Market
based on product type can be further segmented into Cephalosporins, Penicillins, Fluoroquinolones,
Macrolides, Carbapenems, Aminoglycosides, Sulphonamides, and Others. The Cephalosporins Segment held the largest market
share in 2021. This growth is owing to the establishment and
introduction of more novel medications and combinations to treat an extensive
series of bacterial infections. Fluoroquinolones are another type of
antibiotic. The proliferating count of bacterial infections and the burden of
ailments like Tuberculosis in developing and under-developed countries are
further propelling the growth of the Cephalosporins segment.
Furthermore, the Carbapenems segment is estimated to grow with the
fastest CAGR of 5.7% during the forecast period 2022-2027 owing to the proliferating
application of carbapenems as empiric monotherapy in severe conditions like
intra-abdominal infections and infections in neutropenic patients with
investigations indicating that carbapenems were connected with a reduced mortality rate than fluoroquinolones.
Antibiotics
Drugs Market Segment Analysis – By Spectrum Of Activity:
The Antibiotics Drugs
Market based on the spectrum of activity can be further segmented into Broad-Spectrum Antibiotics and Narrow-Spectrum Antibiotics. The Broad-Spectrum Antibiotic Segment held the largest market share in 2021. This growth is owing to the soaring
application of broad-spectrum antibiotics against an extensive series of
ailments which in turn supports the fight against antimicrobial resistance. Fluoroquinolones
have broad-spectrum antimicrobial activity. The surging administration of broad-spectrum
antibiotics empirically before the detection of the exact cause of illness is
further propelling the growth of this segment.
Furthermore, the Broad-Spectrum Antibiotic segment is estimated to grow with the fastest CAGR of 6.1% during the forecast
period 2022-2027 owing to the superior prognosis of broad-spectrum antibiotics
which may include fluoroquinolones
when compared to narrow-spectrum antibiotics when beginning the treatment prior
to recognizing pathogens.
Antibiotics
Drugs Market Segment Analysis – By Geography:
The Antibiotics Drugs
Market based on geography can be further segmented into North America, Europe,
Asia-Pacific, South America, and the Rest of the World. Asia-Pacific (Antibiotics
Drugs Market) held the largest share with 33% of the overall market in 2021.
The growth of this region is owing to the uncontrolled
sales and surplus intake of antibiotics including fluoroquinolones in the region. Fluoroquinolones
and cephalosporins are types of antibiotics. The soaring government initiatives
to establish novel therapies to treat drug-resistant infections and the
existence of the largest markets for antibiotics like India and China in the
region are further driving the growth of the Antibiotics Drugs Market in the Asia-Pacific
region.
Furthermore, the North American region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the soaring acceptance of antibiotics like fluoroquinolones in the North American region. The proliferating adoption of development strategies in conjunction with the surging attention on the establishment of novel anti-infective drugs is further fueling the progress of the Antibiotics Drugs Market in the North American region.
Antibiotics Drugs Market Drivers
Surging Applications Of Fluoroquinolones Are Projected To Drive The Growth Of Antibiotics Drugs Market:
The fluoroquinolones are a family of broad-spectrum, integral antibacterial agents that have been used widely as therapy for respiratory and urinary tract infections. Fluoroquinolones are active against an extensive series of aerobic gram-positive and gram-negative organisms. Gram-positive coverage is inclusive of penicillinase- and non-penicillinase generating Staphylococci, Streptococcus pneumonia, and viridans, Enterococcus faecalis, Listeria monocytogenes, and Nocardia species. Gram-negative coverage is inclusive of Neisseria meningitides and gonorrhea, Haemophilus influenza, and most clinically significant Enterobacteriaceae species, Pseudomonas aeruginosa and Vibrio species. The fluoroquinolones are thought to act by inhibition of type II DNA topoisomerases (gyrases) that are needed for the synthesis of bacterial mRNAs (transcription) and DNA replication. They display little inhibition of human, host enzymes and have had a wonderful safety record. The fluoroquinolones are indicated for the treatment of numerous bacterial contaminations, inclusive of bacterial bronchitis, pneumonia, sinusitis, urinary tract infections, septicemia and intraabdominal contaminations, joint and bone contaminations, soft tissue and skin contaminations, typhoid fever, anthrax, bacterial gastroenteritis, urethral and gynecological contaminations, and pelvic inflammatory disease and numerous additional infectious conditions. The proliferating applications of fluoroquinolones are therefore fuelling the growth of the Antibiotics Drugs Market during the forecast period 2022-2027.
Heightening Applications Of Cephalosporins Are Expected To Boost The Demand Of Antibiotics Drugs Market:
Cephalosporins are a kind of antibiotic that is utilized to treat an assortment of bacterial infections, specifically for people who are allergic to penicillin, another typical antibiotic. Certain examples of infections that cephalosporins can treat involve skin or soft tissue infections, urinary tract infections (UTIs), strep throat, ear infections, pneumonia, sinus infections, meningitis, and gonorrhea. Oral cephalosporins are typically utilized for simple infections that are effortless to treat. For example, a regular case of strep throat might be treated with a course of oral cephalosporins. Intravenous (IV) cephalosporins are utilized for more serious infections owing to the capability of IV antibiotics to arrive at tissues more quickly, which can create a big difference if there is a severe infection, like meningitis. The heightening applications of cephalosporins are therefore driving the growth of the Antibiotics Drugs Market during the forecast period 2022-2027.
Antibiotics Drugs Market Challenges
Limitations Of Antibiotic Drugs Are Hampering The Growth Of The Antibiotics Drugs Market:
Fluoroquinolones and Cephalosporins are types of antibiotic drugs. If antibiotics are consumed frequently, then the body can develop a resistance to antibiotic drugs, which could bring down the efficiency of antibiotics. The lengthier the course of treatment for an antibiotic, the greater the injury that can be done to the immune system of the body. Consuming antibiotics too frequently or for incorrect reasons can alter bacteria so much that antibiotics do not act against them. This is termed bacterial resistance or antibiotic resistance. Some bacteria are now resistant to even the most potent antibiotics accessible. These issues are thus hampering the growth of the Antibiotics Drugs Market.
Antibiotics Drugs Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Antibiotics Drugs Market. Antibiotics Drugs 10 top companies include:
- Pfizer, Inc;
- Janssen Pharmaceuticals
- Abbott laboratories
- GlaxoSmithKline plc
- Sanofi S.A.
- Novartis AG
- Bristol Myers Squibb Company
- Eli Lilly & Company
- Tetraphase Pharmaceuticals Inc
- La Jolla Pharmaceuticals
Recent Developments
- In November 2021, Abbott declared the introduction of a novel initiative planned to support the development of a more inclusive clinical trial ecosystem by way of novel approaches to training, education, and enhancing the clinical research infrastructure within the U.S. This endeavor builds on Abbott's dedication to engaging populations who have historically been under-represented in medical research and will enhance health by boosting access to innovative treatment options accessible within the trials procedure and heightening insights around how distinct groups respond to novel therapies. People of distinct ethnic and cultural backgrounds makeup around 40% of the U.S. population and are disproportionately influenced by incessant conditions like cardiovascular disease and diabetes.
- In October 2021, Sandoz, a Novartis division, has favorably finished the acquisition of GSK’s cephalosporin antibiotics business. By way of this transaction, Sandoz has gained rights to three developed brands (Zinnat, Zinacef, and Fortum)) in over 100 markets, further strengthening its chief global position in antibiotics. In 2020, the three brands had integrated sales of nearly USD 140 million in the appropriate markets.
- In July 2021, Abbott pronounced that it has introduced the COVID-19 home test kit in India for the discovery of the SARS-CoV-2 virus in mature grown-ups and children with or without symptoms at a price of Rs 325 for a single test kit pack. The firm will convey millions of Panbio COVID-19 rapid antigen tests, accessible for self-application, to ease the burden on healthcare systems in urban and rural India, Abbott pronounced in a statement. In alignment with the present ICMR advisory on self-application, these tests will be made accessible to ramp up testing of symptomatic and asymptomatic individuals and contacts of verified coronavirus cases, it indicated.
Related Reports-
Duodenal Ulcer Treatment Market – Forecast (2021 - 2026)
Report Code: HCR 0282
Generic Drugs Market – Forecast (2021 - 2026)
Report Code: HCR 0217
For more Lifesciences and Healthcare related reports, please click here
Table 1 Antibiotics Drugs Market Overview 2023-2030
Table 2 Antibiotics Drugs Market Leader Analysis 2023-2030 (US$)
Table 3 Antibiotics Drugs Market Product Analysis 2023-2030 (US$)
Table 4 Antibiotics Drugs Market End User Analysis 2023-2030 (US$)
Table 5 Antibiotics Drugs Market Patent Analysis 2013-2023* (US$)
Table 6 Antibiotics Drugs Market Financial Analysis 2023-2030 (US$)
Table 7 Antibiotics Drugs Market Driver Analysis 2023-2030 (US$)
Table 8 Antibiotics Drugs Market Challenges Analysis 2023-2030 (US$)
Table 9 Antibiotics Drugs Market Constraint Analysis 2023-2030 (US$)
Table 10 Antibiotics Drugs Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11 Antibiotics Drugs Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12 Antibiotics Drugs Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13 Antibiotics Drugs Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14 Antibiotics Drugs Market Degree of Competition Analysis 2023-2030 (US$)
Table 15 Antibiotics Drugs Market Value Chain Analysis 2023-2030 (US$)
Table 16 Antibiotics Drugs Market Pricing Analysis 2023-2030 (US$)
Table 17 Antibiotics Drugs Market Opportunities Analysis 2023-2030 (US$)
Table 18 Antibiotics Drugs Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19 Antibiotics Drugs Market Supplier Analysis 2023-2030 (US$)
Table 20 Antibiotics Drugs Market Distributor Analysis 2023-2030 (US$)
Table 21 Antibiotics Drugs Market Trend Analysis 2023-2030 (US$)
Table 22 Antibiotics Drugs Market Size 2023 (US$)
Table 23 Antibiotics Drugs Market Forecast Analysis 2023-2030 (US$)
Table 24 Antibiotics Drugs Market Sales Forecast Analysis 2023-2030 (Units)
Table 25 Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 26 Antibiotics Drugs Market By Drug Class, Revenue & Volume,By Phenicols, 2023-2030 ($)
Table 27 Antibiotics Drugs Market By Drug Class, Revenue & Volume,By Quinolones, 2023-2030 ($)
Table 28 Antibiotics Drugs Market By Drug Class, Revenue & Volume,By Macrolides, 2023-2030 ($)
Table 29 Antibiotics Drugs Market By Drug Class, Revenue & Volume,By Sulfonamides, 2023-2030 ($)
Table 30 Antibiotics Drugs Market By Drug Class, Revenue & Volume,By Aminoglycosides, 2023-2030 ($)
Table 31 North America Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 32 South america Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 33 Europe Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 34 APAC Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 35 Middle East & Africa Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 36 Russia Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 37 Israel Antibiotics Drugs Market, Revenue & Volume,By Drug Class, 2023-2030 ($)
Table 38 Top Companies 2023 (US$)Antibiotics Drugs Market, Revenue & Volume
Table 39 Product Launch 2023-2030Antibiotics Drugs Market, Revenue & Volume
Table 40 Mergers & Acquistions 2023-2030Antibiotics Drugs Market, Revenue & Volume
List of Figures
Figure 1 Overview of Antibiotics Drugs Market 2023-2030
Figure 2 Market Share Analysis for Antibiotics Drugs Market 2023 (US$)
Figure 3 Product Comparison in Antibiotics Drugs Market 2023-2030 (US$)
Figure 4 End User Profile for Antibiotics Drugs Market 2023-2030 (US$)
Figure 5 Patent Application and Grant in Antibiotics Drugs Market 2013-2023* (US$)
Figure 6 Top 5 Companies Financial Analysis in Antibiotics Drugs Market 2023-2030 (US$)
Figure 7 Market Entry Strategy in Antibiotics Drugs Market 2023-2030
Figure 8 Ecosystem Analysis in Antibiotics Drugs Market 2023
Figure 9 Average Selling Price in Antibiotics Drugs Market 2023-2030
Figure 10 Top Opportunites in Antibiotics Drugs Market 2023-2030
Figure 11 Market Life Cycle Analysis in Antibiotics Drugs Market
Figure 12 GlobalBy Drug ClassAntibiotics Drugs Market Revenue, 2023-2030 ($)
Figure 13 Global Antibiotics Drugs Market - By Geography
Figure 14 Global Antibiotics Drugs Market Value & Volume, By Geography, 2023-2030 ($)
Figure 15 Global Antibiotics Drugs Market CAGR, By Geography, 2023-2030 (%)
Figure 16 North America Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 17 US Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 18 US GDP and Population, 2023-2030 ($)
Figure 19 US GDP – Composition of 2023, By Sector of Origin
Figure 20 US Export and Import Value & Volume, 2023-2030 ($)
Figure 21 Canada Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 22 Canada GDP and Population, 2023-2030 ($)
Figure 23 Canada GDP – Composition of 2023, By Sector of Origin
Figure 24 Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 25 Mexico Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 26 Mexico GDP and Population, 2023-2030 ($)
Figure 27 Mexico GDP – Composition of 2023, By Sector of Origin
Figure 28 Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 29 South America Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 30 Brazil Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 31 Brazil GDP and Population, 2023-2030 ($)
Figure 32 Brazil GDP – Composition of 2023, By Sector of Origin
Figure 33 Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 34 Venezuela Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 35 Venezuela GDP and Population, 2023-2030 ($)
Figure 36 Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 37 Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 38 Argentina Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 39 Argentina GDP and Population, 2023-2030 ($)
Figure 40 Argentina GDP – Composition of 2023, By Sector of Origin
Figure 41 Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 42 Ecuador Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 43 Ecuador GDP and Population, 2023-2030 ($)
Figure 44 Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 45 Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 46 Peru Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 47 Peru GDP and Population, 2023-2030 ($)
Figure 48 Peru GDP – Composition of 2023, By Sector of Origin
Figure 49 Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 50 Colombia Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 51 Colombia GDP and Population, 2023-2030 ($)
Figure 52 Colombia GDP – Composition of 2023, By Sector of Origin
Figure 53 Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 54 Costa Rica Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 55 Costa Rica GDP and Population, 2023-2030 ($)
Figure 56 Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 57 Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 58 Europe Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 59 U.K Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 60 U.K GDP and Population, 2023-2030 ($)
Figure 61 U.K GDP – Composition of 2023, By Sector of Origin
Figure 62 U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 63 Germany Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 64 Germany GDP and Population, 2023-2030 ($)
Figure 65 Germany GDP – Composition of 2023, By Sector of Origin
Figure 66 Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 67 Italy Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 68 Italy GDP and Population, 2023-2030 ($)
Figure 69 Italy GDP – Composition of 2023, By Sector of Origin
Figure 70 Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 71 France Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 72 France GDP and Population, 2023-2030 ($)
Figure 73 France GDP – Composition of 2023, By Sector of Origin
Figure 74 France Export and Import Value & Volume, 2023-2030 ($)
Figure 75 Netherlands Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 76 Netherlands GDP and Population, 2023-2030 ($)
Figure 77 Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 78 Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 79 Belgium Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 80 Belgium GDP and Population, 2023-2030 ($)
Figure 81 Belgium GDP – Composition of 2023, By Sector of Origin
Figure 82 Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 83 Spain Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 84 Spain GDP and Population, 2023-2030 ($)
Figure 85 Spain GDP – Composition of 2023, By Sector of Origin
Figure 86 Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 87 Denmark Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 88 Denmark GDP and Population, 2023-2030 ($)
Figure 89 Denmark GDP – Composition of 2023, By Sector of Origin
Figure 90 Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 91 APAC Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 92 China Antibiotics Drugs Market Value & Volume, 2023-2030
Figure 93 China GDP and Population, 2023-2030 ($)
Figure 94 China GDP – Composition of 2023, By Sector of Origin
Figure 95 China Export and Import Value & Volume, 2023-2030 ($)Antibiotics Drugs Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 96 Australia Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 97 Australia GDP and Population, 2023-2030 ($)
Figure 98 Australia GDP – Composition of 2023, By Sector of Origin
Figure 99 Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 100 South Korea Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 101 South Korea GDP and Population, 2023-2030 ($)
Figure 102 South Korea GDP – Composition of 2023, By Sector of Origin
Figure 103 South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 104 India Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 105 India GDP and Population, 2023-2030 ($)
Figure 106 India GDP – Composition of 2023, By Sector of Origin
Figure 107 India Export and Import Value & Volume, 2023-2030 ($)
Figure 108 Taiwan Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 109 Taiwan GDP and Population, 2023-2030 ($)
Figure 110 Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 111 Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 112 Malaysia Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 113 Malaysia GDP and Population, 2023-2030 ($)
Figure 114 Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 115 Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 116 Hong Kong Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 117 Hong Kong GDP and Population, 2023-2030 ($)
Figure 118 Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 119 Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 120 Middle East & Africa Antibiotics Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 121 Russia Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 122 Russia GDP and Population, 2023-2030 ($)
Figure 123 Russia GDP – Composition of 2023, By Sector of Origin
Figure 124 Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 125 Israel Antibiotics Drugs Market Value & Volume, 2023-2030 ($)
Figure 126 Israel GDP and Population, 2023-2030 ($)
Figure 127 Israel GDP – Composition of 2023, By Sector of Origin
Figure 128 Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 129 Entropy Share, By Strategies, 2023-2030* (%)Antibiotics Drugs Market
Figure 130 Developments, 2023-2030*Antibiotics Drugs Market
Figure 131 Company 1 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 132 Company 1 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 133 Company 1 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 134 Company 2 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 135 Company 2 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 136 Company 2 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 137 Company 3Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 138 Company 3Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 139 Company 3Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 140 Company 4 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 141 Company 4 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 142 Company 4 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 143 Company 5 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 144 Company 5 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 145 Company 5 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 146 Company 6 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 147 Company 6 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 148 Company 6 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 149 Company 7 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 150 Company 7 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 151 Company 7 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 152 Company 8 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 153 Company 8 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 154 Company 8 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 155 Company 9 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 156 Company 9 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 157 Company 9 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 158 Company 10 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 159 Company 10 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 160 Company 10 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 161 Company 11 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 162 Company 11 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 163 Company 11 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 164 Company 12 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 165 Company 12 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 166 Company 12 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 167 Company 13Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 168 Company 13Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 169 Company 13Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 170 Company 14 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 171 Company 14 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 172 Company 14 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)
Figure 173 Company 15 Antibiotics Drugs Market Net Revenue, By Years, 2023-2030* ($)
Figure 174 Company 15 Antibiotics Drugs Market Net Revenue Share, By Business segments, 2023 (%)
Figure 175 Company 15 Antibiotics Drugs Market Net Sales Share, By Geography, 2023 (%)